BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28738015)

  • 1. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
    Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC
    Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
    Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
    Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
    Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation of Selective Neonatal Bacillus Calmette-Guérin Vaccination of High-risk Infants in Ireland.
    Teljeur C; Moran PS; Harrington P; Butler K; Corcoran B; O'Donnell J; Usher C; O'Flanagan D; Connolly K; Ryan M
    Pediatr Infect Dis J; 2018 Aug; 37(8):759-767. PubMed ID: 29432385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.
    Nguipdop-Djomo P; Heldal E; Rodrigues LC; Abubakar I; Mangtani P
    Lancet Infect Dis; 2016 Feb; 16(2):219-26. PubMed ID: 26603173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
    Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
    JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of BCG Vaccination Against Mycobacterium tuberculosis Infection in Adults: A Cross-sectional Analysis of a UK-Based Cohort.
    Katelaris AL; Jackson C; Southern J; Gupta RK; Drobniewski F; Lalvani A; Lipman M; Mangtani P; Abubakar I
    J Infect Dis; 2020 Jan; 221(1):146-155. PubMed ID: 31504674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
    You NN; Liu Q; Zhu LM; Lu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.
    Abbott S; Christensen H; Lalor MK; Zenner D; Campbell C; Ramsay ME; Brooks-Pollock E
    Vaccine; 2019 Aug; 37(35):5067-5072. PubMed ID: 31296375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
    Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
    Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.